News

The Annual Meeting of the American Society for Radiation Oncology (ASTRO) conference in Boston, September 26 – 28, will see Xstrahl Ltd (Booth 7057) showcase a range of new and updated products and systems. The Medical side of the business will be presenting the updated Photoelectric Therapy system, whilst Xstrahl Life Sciences highlights the recent developments and new accessories for SARRP. The ASTRO Annual Meeting is the world’s most important meeting for the radiation oncology community, with more than 11,000 people attending.

NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB)1 stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using Xstrahl distributed Xoft Axxent eBx as a treatment option for early stage breast cancer patients. A single dose of intraoperative radiotherapy (IORT) is an effective and convenient alternative to daily conventional radiotherapy for appropriate early stage breast cancer patients.

Xstrahl (Booth B29) will showcase the next generation in 3rd party connectivity for Xstrahl systems at this year’s Deutschen Gesellschaft für Radioonkologie e.V. (DEGRO) in Mannheim, Germany from 16th – 19th June. XBridge offers Xstrahl users the ability to communicate with 3rd party clinical information systems, enabling data import of patient demographics and export of treatment information, ensuring traceability throughout a patient’s treatment.

Xstrahl Medical (Booth 6300) will introduce the next generation in 3rd party connectivity for Xstrahl systems at ESTRO35 in Turin, Italy on Saturday 30th April. XBridge offers Xstrahl users the ability to communicate with 3rd party clinical information systems, enabling data import of patient demographics and export of treatment information, ensuring traceability throughout a patient’s treatment.

What could you do with a SARRP? Take a look at some of the amazing research being presented at AACR 2016 with the help of this cutting edge equipment.

Xstrahl Life Sciences will be showcasing the recent developments for SARRP at ESTRO35 in Turin, Italy on Saturday 30th April. The Xstrahl booth (6300) will allow attendees to learn about how cancer research is being enhanced by the Xstrahl SARRP Image Guided Micro-Irradiator. A number of posters and presentations are being given at ESTRO35 that were developed with the help of Xstrahl Life Sciences products.

Xstrahl’s mission is to enable the most advanced radiation research, by producing clinically relevant research platforms. The Xstrahl SARRP research platform is an advanced irradiation device that allows researchers to refine cancer care. University of California San Francisco (UCSF) will take delivery of SARRP 50 in April and will join an ever growing SARRP community.